Picture of Voyager Therapeutics logo

VYGR — Voyager Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Voyager Enters Into License For Next-Generation Capsid, Bringing Partnered Portfolio Of Tracer-Enabled Gene Therapies To 14

Novartis AG  NOVN.S :
    * VOYAGER ENTERS INTO LICENSE FOR NEXT-GENERATION CAPSID,
BRINGING
PARTNERED PORTFOLIO OF TRACER-ENABLED GENE THERAPIES TO 14
    * VOYAGER THERAPEUTICS: TO GET $15M UPFRONT, ELIGIBLE TO GET
UP TO
$305 MILLION IN ASSOCIATED MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNXbWxl31 
Further company coverage:  NOVN.S

Recent news on Voyager Therapeutics

See all news